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Materials Design Analysis Reporting (MDAR)  
Checklist for Authors 
 
The MDAR framework establishes a minimum set of requirements in transparent reporting applicable to studies in the life sciences 
(see Statement of Task: doi:10.31222/osf.io/9sm4x.). The MDAR checklist is a tool for authors, editors and others seeking to adopt 
the MDAR framework for transparent reporting in manuscripts and other outputs.   Please refer to the MDAR Elaboration 
Document for additional context for the MDAR framework.   
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Materials 
 
Antibodies Yes  (indicate where provided: page no/section/legend) n/a 
For commercial reagents, provide supplier 
name, catalogue number and RRID, if available. 
Yes. Supplementary Materials/Materials and 
Methods/Immunohistochemistry/ page 2-3 
 
   
Cell materials Yes  (indicate where provided: page no/section/legend) n/a 
Cell lines: Provide species information, strain. 
Provide accession number in repository OR 
supplier name, catalog number, clone number, 
OR RRID 
 n/a 
Primary cultures: Provide species, strain, sex of 
origin, genetic modification status. 
 n/a 
   
Experimental animals Yes  (indicate where provided: page no/section/legend) n/a 
Laboratory animals: Provide species, strain, sex, age, 
genetic modification status. Provide accession 
number in repository OR supplier name, catalog 
number, clone number, OR RRID 
 
 n/a 
Animal observed in or captured from the 
field: Provide species, sex and age where 
possible 
 n/a 
Model organisms: Provide Accession number 
in repository (where relevant) OR RRID 
 n/a 
   
Plants and microbes Yes  (indicate where provided: page no/section/legend) n/a 
Plants: provide species and strain, unique accession 
number if available, and source (including location 
for collected wild specimens) 
 
Yes. Supplementary Materials/Materials and 
Methods/Plant growth conditions/references 2 and 29/ 
page 2 
 
Microbes: provide species and strain, unique 
accession number if available, and source 
 n/a 
   
Human research participants Yes  (indicate where provided: page no/section/legend) n/a 
Identify authority granting ethics approval (IRB or 
equivalent committee(s), provide reference number 
for approval.  
 
 n/a 
Provide statement confirming informed consent 
obtained from study participants. 
 
 n/a 
Report on age and sex for all study participants.  n/a 
 
  
3 
 
Design 
 
Study protocol Yes  (indicate where provided: page no/section/legend) n/a 
For clinical trials, provide the trial registration 
number OR cite DOI in manuscript. 
 
  
 n/a 
   
Laboratory protocol Yes  (indicate where provided: page no/section/legend) n/a 
Provide DOI or other citation details if detailed step-
by-step protocols are available.  
 
 
 n/a 
   
Experimental study design (statistics details) Yes  (indicate where provided: page no/section/legend) n/a 
State whether and how the following have been 
done, or if they were not carried out. 
  
Sample size determination 
 
not carried out  
Randomisation 
 
not carried out  
Blinding 
 
not carried out  
Inclusion/exclusion criteria 
 
not carried out  
  
Sample definition and in-laboratory replication Yes  (indicate where provided: page no/section/legend) n/a 
State number of times the experiment was 
replicated in laboratory 
Yes. Figures legends  
Define whether data describe technical or biological 
replicates 
Yes. Supplementary Materials/Materials and 
Methods/dSTORM/ page 3-4 
 
   
Ethics Yes  (indicate where provided: page no/section/legend) n/a 
Studies involving human participants: State details of 
authority granting ethics approval (IRB or equivalent 
committee(s), provide reference number for 
approval.  
 n/a 
Studies involving experimental animals: State details 
of authority granting ethics approval (IRB or 
equivalent committee(s), provide reference number 
for approval. 
 n/a 
Studies involving specimen and field samples: State if 
relevant permits obtained, provide details of 
authority approving study; if none were required, 
explain why. 
 n/a 
   
Dual Use Research of Concern (DURC) Yes  (indicate where provided: page no/section/legend) n/a 
If study is subject to dual use research of concern, 
state the authority granting approval and reference 
number for the regulatory approval 
 n/a 
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Analysis 
 
Attrition Yes  (indicate where provided: page no/section/legend) n/a 
State if sample or data point from the analysis is 
excluded, and whether the criteria for exclusion were 
determined and specified in advance. 
Yes. The criterial for exclusion were determined in 
advance. For instance, for dSTORM microscopy, if there 
was not enough molecules localized to reconstruct the 
image, or if the signal-to-noise ratio was to low to 
achieve the localization with high precision. 
 
   
Statistics Yes  (indicate where provided: page no/section/legend) n/a 
Describe statistical tests used and justify choice of 
tests. 
 
Yes. Supplementary Materials/Materials and 
Methods/Statistical Analysis/ page 5 
 
   
Data Availability Yes  (indicate where provided: page no/section/legend) n/a 
State whether newly created datasets are available, 
including protocols for access or restriction on 
access. 
The data used in this study are available without any 
restriction.  
 
If data are publicly available, provide accession 
number in repository or DOI or URL. 
DOI: 10.17632/xb3f5jrbwv.1  
If publicly available data are reused, provide 
accession number in repository or DOI or URL, where 
possible. 
 n/a 
   
Code Availability Yes  (indicate where provided: page no/section/legend) n/a 
For all newly generated code and software essential 
for replicating the main findings of the study: 
All the codes used in this study are available  
State whether the code or software is available. All the codes are available at GitHub or  Zenodo  
If code is publicly available, provide accession 
number in repository, or DOI or URL. 
DOI: 10.5281/zenodo.3581144 , DOI: 
10.5281/zenodo.3581097 , DOI: 10.5281/zenodo.3581129 ,  
DOI: 10.5281/zenodo.3581151  
 
 
Reporting 
 
Adherence to community standards Yes  (indicate where provided: page no/section/legend) n/a 
MDAR framework recommends adoption of 
discipline-specific guidelines, established and 
endorsed through community initiatives. Journals 
have their own policy about requiring specific 
guidelines and recommendations to complement 
MDAR.  
We have followed the “minimum standards” for 
scientific reporting by: providing detailed description of 
the methods, analyses and materials used in this study, 
publishing codes developed and used in this study, 
publishing the new datasets at the public repository. 
 
State if relevant guidelines (eg., ICMJE, MIBBI, 
ARRIVE) have been followed, and whether a checklist 
(eg., CONSORT, PRISMA, ARRIVE) is provided with 
the manuscript.  
We have followed MIBBI guidelines. The datasets are 
available at public repositories. The codes and 
analytical tools developed for this study are described 
and freely available for download. 
 
 
 
